World Health Organization
|
|
|
|
|
| |
Guidelines for the diagnosis and management of Cystic Fibrosis
CONTENTS
GENETICS
PATHOGENESIS
Respiratory
System
Infection
Pancreas
Intestines
Liver
Skin
Reproductive System
CLINICAL
FEATURES
Presenting Features
At birth
In the first year
In the pre-school age
child
In the school age child
In adolescence and adult life
DIAGNOSIS
The Sweat
Test
Genetic Testing
Neonatal Screening
Tests for Pancreatic Insufficiency
MANAGEMENT
The Newly-Diagnosed
Patient
Surveillance
Routine Management
Treatment of Pulmonary
Manifestations
Physiotherapy
Exercise
Treatment of respiratory infection
Staphylococcus
aureus
Haemophilus influenzae
Pseudomonas aeruginosa
Aerosol antibiotics
Burkholderia
cepacia
Aspergillus
Other Respiratory Therapy
Gene Therapy
Pulmonary Function
Tests
Treatment of Pancreatic Insufficiency
Nutritional Management
Treatment of Meconium
Ileus
Treatment of Distal Intestinal Obstruction Syndrome (DIOS)
Management of Late and Less
Common Complications
FURTHER READING
ACKNOWLEDGEMENTS
ANNEX
Physiotherapy in the Treatment of Cystic Fibrosis
|
|
|
|
|
|
|
| |
| |
|
|
|
|
| |
5 for 5 Campaign
 |
|
|
|
|
|
